Navigation Links
Raloxifene Better Than Tamoxifen For Breast Cancer

The osteoporosis drug Evista is better than Tamoxifen in preventing breast cancer in high risk post-menopausal women, new research// has suggested. Researchers said that both drugs reduce the risk of cancer by 50 percent. But the results of a 19,000-woman trial show that Eli Lilly and Co's Evista, known generically as raloxifene has fewer side effects. This fact could prompt clinicians to replace Tamoxifen with Evista in the future.

Raloxifene was found to cause less of blood clots, cataracts and uterine cancer than tamoxifen in the trial. "It is clear that raloxifene is the winner of this trial," said lead researcher Dr. Norman Wolmark, a researcher at the University of Pittsburgh Medical Center. Tamoxifen is sold as a generic drug and is widely used to prevent breast cancer, but Lilly said it would seek U.S. Food and Drug Administration approval to market Evista for this purpose. "Tamoxifen will remain the drug of choice for reducing breast cancer risk in pre-menopausal women," Vogel said. However, Raloxifene was found to cause more pre-cancerous lesions, which has puzzled doctors. "For now it will be very important for women with an increased risk of breast cancer to make an informed decision with the advice of their physician," the group said. "It is also important to note that while both drugs can prevent many breast cancers, neither has been shown to reduce the risk of death due to the disease." Of the 9,745 women in the raloxifene group, 167 developed invasive breast cancer, compared to 163 of 9,726 women in the tamoxifen group.
'"/>




Page: 1

Related medicine news :

1. Raloxifene Reduces The Risk Of Breast Cancer
2. Better prostate cancer detection
3. Better Treatment for obesity
4. For a Better Memory
5. Baby Talk Better Than Adult Speech
6. Drug Combo Works Better for children with ADHD, Tics
7. Better skin with lasers
8. Better diabetes treatment promises Vanadium
9. Better Prostate Cancer Test
10. Better Drug for Heart Transplant
11. Better Diet Even Late in Life May Prolong It
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: